The Potential Role of Vedolizumab in Concomitant Eosinophilic Esophagitis and Crohn's Disease

Research output: Contribution to journal › Letter

5 Scopus citations

Original language	English (US)
Pages (from-to)	1840-1841
Number of pages	2
Journal	Clinical Gastroenterology and Hepatology
Volume	16
Issue number	11
DOIs	https://doi.org/10.1016/j.cgh.2018.06.022
State	Published - Nov 2018

Cite this

@article{29ffce8d594248a08286272593dff1f5,

title = "The Potential Role of Vedolizumab in Concomitant Eosinophilic Esophagitis and Crohn's Disease",

author = "Taft, {Tiffany H.} and Mutlu, {Ece A.}",

year = "2018",

month = nov,

doi = "10.1016/j.cgh.2018.06.022",

language = "English (US)",

volume = "16",

pages = "1840--1841",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders Ltd",

number = "11",

}

TY - JOUR

T1 - The Potential Role of Vedolizumab in Concomitant Eosinophilic Esophagitis and Crohn's Disease

AU - Taft, Tiffany H.

AU - Mutlu, Ece A.

PY - 2018/11

Y1 - 2018/11

UR - http://www.scopus.com/inward/record.url?scp=85055048835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055048835&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2018.06.022

DO - 10.1016/j.cgh.2018.06.022

M3 - Letter

C2 - 30343868

AN - SCOPUS:85055048835

VL - 16

SP - 1840

EP - 1841

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 11

ER -